-
2761“…Fidelity ratings and dropout rates varied substantially between counsellors. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2762por Patil, Vijay Maruti, Noronha, Vanita, Joshi, Amit, Choughule, Anuradha Bharat, Bhattacharjee, Atanu, Kumar, Rajiv, Goud, Supriya, More, Sucheta, Ramaswamy, Anant, Karpe, Ashay, Pande, Nikhil, Chandrasekharan, Arun, Goel, Alok, Talreja, Vikas, Mahajan, Abhishek, Janu, Amit, Purandare, Nilendu, Prabhash, Kumar“…The primary endpoint for the study was PFS. 260 patients were required to demonstrate a 50% improvement in PFS of gefitinib over chemotherapy, with 80% power and 5% type 1 error. With an expected 5% dropout rate, the sample size was 290 patients. RESULTS: The median PFS in gefitinib arm was 8.4 months (95% CI 6.3 to 10.5 months) compared with 5.6 months (95% CI 4.2 to 7.0 months) in pemetrexed–carboplatin arm (HR: 95% CI 0.513 to 0.851; p −0.001). …”
Publicado 2017
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2763por McIntyre, Cecily, Harris, Meredith G., Baxter, Amanda J., Leske, Stuart, Diminic, Sandra, Gone, Joseph P., Hunter, Ernest, Whiteford, Harvey“…Less than half included questions about interventions received, hospital admissions or treatment dropout. Indigenous-specific content was most common in questions regarding use of support services or self-management, types of health professionals consulted, barriers to care and interventions received. …”
Publicado 2017
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2764por Levinger, Pazit, Dunn, Jeremy, Bifera, Nancy, Butson, Michael, Elias, George, Hill, Keith D.“…Feasibility and safety will be assessed by examining adherence to the exercise program, dropout rate, pain level during and following exercise, number of exercises stopped due to pain, and any adverse event or any incident that prevents the participant from completing the prescribed exercise. …”
Publicado 2017
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2765por Patel, Shnehal, Ojo, Oluwadamilola, Genc, Gencer, Oravivattanakul, Srivadee, Huo, Yang, Rasameesoraj, Tanaporn, Wang, Lu, Bena, James, Drerup, Michelle, Foldvary-Schaefer, Nancy, Ahmed, Anwar, Fernandez, Hubert H.“…However, in an intention-to-treat analysis, where all enrolled subjects were included, the change in ISI between groups was not significant (−.4.5 vs −3.3; p = 0.48), likely due to the high dropout rate in the CCBT-I group (43%). CONCLUSION: This pilot study suggests that CCBT-I can be an effective treatment option for PD patients with insomnia when the course is thoroughly completed. …”
Publicado 2017
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2766por Zajonz, Dirk, Birke, Undine, Ghanem, Mohamed, Prietzel, Torsten, Josten, Christoph, Roth, Andreas, Fakler, Johannes K.M.“…RESULTS: The median follow-up period was 72 months, ranging from 6 to 267 months. The dropout rate was 5.8%. The reinfection rate after healed reinfection in SCG was 40% (8/20), in NSCG 57% (8/14), p = 0.34; α =0.05. …”
Publicado 2017
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2767por Meng, Ge, Wang, Honglei, Pei, Yinghua, Li, Yanmei, Wu, Hongmei, Song, Yanqi, Guo, Qi, Guo, Hui, Fukushima, Shinobu, Tatefuji, Tomoki, Wang, Jiazhong, Du, Huanmin, Su, Qian, Zhang, Wen, Shen, Suxing, Wang, Xiuyang, Dong, Renwei, Han, Peipei, Okazaki, Tatsuma, Nagatomi, Ryoichi, Wang, Jianhua, Huang, Guowei, Sun, Zhong, Song, Kun, Niu, Kaijun“…Secondary outcomes include several physical performance tests (six-minute walk test, timed up and go test, and standing on one leg with eyes closed). The dropout rate was 16.0%. The means (95% confidence interval) of change in handgrip strength for placebo, low-dose, and high-dose groups are −0.98(−2.04,0.08), 0.50(−0.65,1.65) and 1.03(−0.37,2.44) kg (P = 0.06, P for trend = 0.02), respectively. …”
Publicado 2017
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2768por Zhou, Xinyu, Cipriani, Andrea, Zhang, Yuqing, Cuijpers, Pim, Hetrick, Sarah E, Weisz, John R, Pu, Juncai, Giovane, Cinzia Del, Furukawa, Toshiaki A, Barth, Jürgen, Coghill, David, Leucht, Stefan, Yang, Lining, Ravindran, Arun V, Xie, Peng“…The primary outcomes will be efficacy (mean change in depressive symptoms), and acceptability of treatment (dropout rate due to any cause). The secondary outcomes will be remission rate, tolerability of treatment (dropouts for adverse events), as well as suicide-related outcomes (suicidal behaviour or ideation). …”
Publicado 2017
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2769por Grant, Sean, Colaiaco, Benjamin, Motala, Aneesa, Shanman, Roberta, Booth, Marika, Sorbero, Melony, Hempel, Susanne“…We did not detect statistically significant differences between MBRP and comparators on relapse (odds ratio [OR] 0.72, 95% confidence interval [CI] 0.46–1.13, low QoE), frequency of use (standardized mean difference [SMD] 0.02, 95% CI −0.40 to 0.44, low QoE), treatment dropout (OR 0.81, 95% CI 0.40 to 1.62, very low QoE), depressive symptoms (SMD −0.09, 95% CI −0.39 to 0.21, low QoE), anxiety symptoms (SMD −0.32, 95% CI −1.16 to 0.52, very low QoE), and mindfulness (SMD −0.28, 95% CI −0.72 to 0.16, very low QoE). …”
Publicado 2017
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2770por Day, Richard O, Frensham, Lauren J, Nguyen, Amy D, Baysari, Melissa T, Aung, Eindra, Lau, Annie Y S, Zwar, Nicholas, Reath, Jennifer, Laba, Tracey, Li, Ling, McLachlan, Andrew, Runciman, William B, Buchbinder, Rachelle, Clay-Williams, Robyn, Coiera, Enrico, Braithwaite, Jeffrey, McNeil, H Patrick, Hunter, David J, Pile, Kevin D, Portek, Ian, WIlliams, Kenneth Mapson, Westbrook, Johanna I“…The study is designed to detect a ≥30% improvement in the intervention group above the expected 50% achievement of target serum urate at 6 months in the control group: power 0.80, significance level 0.05, assumed ‘dropout’ rate 20%. ETHICS AND DISSEMINATION: This study has been approved by the University of New South Wales Human Research Ethics Committee. …”
Publicado 2017
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2771por Pepin, Jean Louis, Gagnadoux, Frédéric, Foote, Alison, Vicars, Rachel, Ogra, Bhavi, Viot-Blanc, Véronique, Benmerad, Meriem, D’Ortho, Marie-Pia, Tamisier, Renaud“…After an evaluation visit, patients are switched to the other treatment arm for a further 4 weeks. Allowing for 20% dropout, 48 patients are required. If applicable, repeated measures analysis of variance will be used to assess differences in WASO measured by actigraphy (primary outcome), other actigraphy measures, AutoCPAP compliance, subjective questionnaire scores (Epworth Sleepiness Scale, Pittsburgh Sleep Quality Index, Short-Form 12 Health Survey) and 24 hours blood pressure (secondary outcomes). …”
Publicado 2017
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2772por Djabelkhir, Leila, Wu, Ya-Huei, Vidal, Jean-Sébastien, Cristancho-Lacroix, Victoria, Marlats, Fabienne, Lenoir, Hermine, Carno, Ariela, Rigaud, Anne-Sophie“…Attrition rate was very low (one dropout at M3 assessment). At M3, the CCS participants displayed a significant improvement in part B of the Trail Making Test (TMT-B; p=0.03) and self-esteem (p=0.005), while the CCE participants showed a significant improvement in part A of the Trail Making Test (TMT-A; p=0.007) and a higher level of technology acceptance (p=0.006). …”
Publicado 2017
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2773por Xue, Xiaonan, Agalliu, Ilir, Kim, Mimi Y., Wang, Tao, Lin, Juan, Ghavamian, Reza, Strickler, Howard D.“…METHODS: We propose a new definition for the follow-up rate, the Person-Time Follow-up Rate (PTFR), which is the observed person-time divided by total person-time assuming no dropouts. The PTFR cannot be calculated directly since the event times for dropouts are not observed. …”
Publicado 2017
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2774“…A log-rank test showed no evidence of a difference in dropout rates between task variants (χ(2)(2)=3.0, P=.22), and a one-way analysis of variance of the mean number of sessions completed per participant in each variant also showed no evidence of a difference (F(2,262)=1.534, P=.21, partial η(2)=0.012). …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2775“…RESULTS: Linear regression of the ΔIIEF-EF score from baseline to 12 months included 95 patients (dropout rate = 25%). Adjusted for the IIEF-EF score at baseline, the difference between groups B and A was −1.30 (95% CI = −4.37 to 1.77, P = .4). …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2776“…Because the major challenge is to decrease the high dropout of 1st-generation PDE5is, further studies will be needed to clarify this topic. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2777por Li, Shanshan, Zhang, Xinjiang, Fang, Qi, Zhou, Junshan, Zhang, Meijuan, Wang, Hui, Chen, Yan, Xu, Biyun, Wu, Yanfeng, Qian, Lai, Xu, Yun“…With 18 patients lost to follow-up, the dropout rate was 5.17%. Admission data between two groups were similar, but in the GBE group there was a marked slow down in the decline in the Montreal Cognitive Assessment scores (−2.77±0.21 vs −1.99±0.23, P=0.0116 (30 days); −3.34±0.24 vs −2.48±0.26, P=0.0165 (90 days); −4.00±0.26 vs −2.71±0.26, P=0.0004 (180 days)) compared with controls. …”
Publicado 2017
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2778“…Based on an objective success rate of 90%, a noninferiority margin of 15%, and a dropout of 20%, 107 patients are needed in each arm to prove the hypothesis with a 95% confidence interval. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2779por Patel, Naimish R, Cunoosamy, Danen M, Fagerås, Malin, Taib, Ziad, Asimus, Sara, Hegelund-Myrbäck, Tove, Lundin, Sofia, Pardali, Katerina, Kurian, Nisha, Ersdal, Eva, Kristensson, Cecilia, Korsback, Katarina, Palmér, Robert, Brown, Mary N, Greenaway, Steven, Siew, Leonard, Clarke, Graham W, Rennard, Stephen I, Make, Barry J, Wise, Robert A, Jansson, Paul“…In the 213 patients randomized into the Proof of Principle study, there was no statistically significant difference between AZD7624 and placebo when comparing the number of days to the first moderate or severe exacerbation or early dropout. CONCLUSION: Although p38α is upregulated in the lungs of COPD patients, AZD7624, an isoform-specific inhaled p38 MAPK inhibitor, failed to show any benefit in patients with COPD.…”
Publicado 2018
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2780“…Analyses were restricted to freshman and sophomores given significant high school dropout rates among older students. School population weighted results are presented based on the YRBS complex survey design, including comparisons of reported gun carrying across survey waves and cities. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto